
Keywords: Microtubule destabilizing agents; Esophageal squamous cell carcinoma; Antitumor effect; Apoptosis; Vascular disrupting agents; AC-α-tubulin; acetylated-α-tubulin; CA4; combretastatin A-4; DAPI; 6-diamidino-2-phenylindole; ESCC; esophageal squamous cell